SCHEMBL20021336

SCHEMBL20021336

Cc1ccc(C(=O)Nc2ccc(-c3ccc(-n4cnc(C)c4)c(CO)n3)nn2)cc1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 13/20 0.56
PSEN2 P49810 13/20 0.56
APH1B Q8WW43 13/20 0.56
NCSTN Q92542 13/20 0.56
APH1A Q96BI3 13/20 0.56
PSENEN Q9NZ42 13/20 0.56
LDLR P01130 1/20 0.41
PCSK9 Q8NBP7 1/20 0.41
RAB9A P51151 3/20 0.38
TP53 P04637 1/20 0.38
TSHR P16473 1/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPC1 O15118 2/20 0.37
MAP3K5 Q99683 2/20 0.36
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20021452 0.93 PSEN1 (0.67) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL20021340 0.82 PSEN1 (0.55) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL17714371 0.79 PSEN1 (0.72) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL20021451 0.76 PSEN1 (0.37) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL20021450 0.76 PSEN1 (0.65) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL20021454 0.75 PSEN1 (0.66) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL20021362 0.75 PSEN1 (0.64) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL20021403 0.72 PSEN1 (0.36) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL20021330 0.72 PSEN1 (0.43) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL20021431 0.72 PSEN1 (0.40) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180093967-A1 POTENT GAMMA-SECRETASE MODULATORS THE GENERAL HOSPITAL CORPORATION 2018-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180093967-A1 POTENT GAMMA-SECRETASE MODULATORS BACE1, BACE2, APP PSEN1 4/4885PSEN2 7/4885APH1B 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.